4//SEC Filing
Matthews Judith M. 4
Accession 0001209191-18-034193
CIK 0001659323other
Filed
May 29, 8:00 PM ET
Accepted
May 30, 5:12 PM ET
Size
16.5 KB
Accession
0001209191-18-034193
Insider Transaction Report
Form 4
Matthews Judith M.
Chief Financial Officer
Transactions
- Conversion
Ordinary Shares
2018-05-30+3,038→ 49,664 total - Purchase
Ordinary Shares
2018-05-30$13.00/sh+4,000$52,000→ 56,130 total - Conversion
Series B-1 Preferred Shares
2018-05-30−3,038→ 0 total→ Ordinary Shares (3,038 underlying) - Conversion
Series B-2 Preferred Shares
2018-05-30−2,466→ 0 total→ Ordinary Shares (2,466 underlying) - Conversion
Ordinary Shares
2018-05-30+10,980→ 46,626 total - Conversion
Ordinary Shares
2018-05-30+2,466→ 52,130 total - Conversion
Series A Preferred Shares
2018-05-30−10,980→ 0 total→ Ordinary Shares (10,980 underlying)
Footnotes (4)
- [F1]The Series A Preferred Shares automatically converted into Ordinary Shares of the Issuer on a 1-to-1 basis upon closing of the initial public offering of the Issuer.
- [F2]The Series B-1 Preferred Shares automatically converted into Ordinary Shares of the Issuer on a 1-to-1 basis upon closing of the initial public offering of the Issuer.
- [F3]The Series B-2 Preferred Shares automatically converted into Ordinary Shares of the Issuer on a 1-to-1 basis upon closing of the initial public offering of the Issuer.
- [F4]Not applicable.
Documents
Issuer
Iterum Therapeutics plc
CIK 0001659323
Entity typeother
Related Parties
1- filerCIK 0001734033
Filing Metadata
- Form type
- 4
- Filed
- May 29, 8:00 PM ET
- Accepted
- May 30, 5:12 PM ET
- Size
- 16.5 KB